Paraganglioma

• CLINICAL_TRIALS trial_result · 2017-01-19
  Clinical Trial Update: Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors [Phase 2]

  Phase 2 trial of linsitinib in patients with gastrointestinal stromal tumors (and related conditions) has completed with results posted.

• CLINICAL_TRIALS trial_result · 2016-07-21
  Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma [Phase 2]

  Phase 2 trial of pazopanib hydrochloride in advanced or progressive malignant pheochromocytoma or paraganglioma was terminated with results …

• CLINICAL_TRIALS trial_result · 2016-07-15
  Clinical Trial Update: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma [Phase 1]

  Phase 1 clinical trial evaluating the combination of Cixutumumab, Everolimus, and Octreotide acetate in patients with advanced low- to inter…

• CLINICAL_TRIALS trial_result · 2016-06-13
  Clinical Trial Update: Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors [Phase 1]

  A Phase 1 trial evaluating the combination of temsirolimus and vinorelbine ditartrate in adults with unresectable or metastatic solid tumors…

• CLINICAL_TRIALS trial_result · 2016-04-20
  Clinical Trial Update: Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma [Phase 1, Phase 2]

  Phase 1/2 study of iobenguane I-131 (MIBG) in patients with malignant pheochromocytoma or paraganglioma completed; results were posted in 20…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-07-23
  Clinical Trial Update: Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers [NA]

  This completed clinical trial evaluated screening methods to detect tumors in SDH-positive carriers, addressing hereditary paraganglioma and…

• CLINICAL_TRIALS trial_result · 2015-05-20
  Clinical Trial Update: RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid [Phase 2]

  A Phase 2 trial of RAD001 (everolimus) for pheochromocytoma, extra-adrenal paraganglioma, and non-functioning carcinoid has completed.

• CLINICAL_TRIALS trial_result · 2014-02-25
  Clinical Trial Update: Feasibility of 123I-IBZM Scintigraphy (a D2 Agonist) in Patients With Pheochromocytoma (PHEO) and/or Paraganglioma (PGL) : Study Pilot [NA]

  A completed pilot study assessing the feasibility of Iodine-123 IBZM scintigraphy as a diagnostic imaging tool in patients with pheochromocy…

• CLINICAL_TRIALS trial_result · 2011-10-12
  Clinical Trial Update: ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid [Phase 1]

  Phase 1 clinical trial of Ultratrace iobenguane I-131 in patients with malignant pheochromocytoma, paraganglioma, or metastatic carcinoid ha…

• CLINICAL_TRIALS trial_result · 2011-06-15
  Clinical Trial Update: 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors [Phase 3]

  This is a Phase 3 clinical trial update evaluating 123I‑MIBG scintigraphy for evaluating patients with suspected neuroendocrine tumors, incl…